Why the study?
Does imidapril improve forearm blood flow response to reactive hyperemia compared to amlodipine in patients with varying severities of essential hypertension?
Does imidapril improve forearm blood flow response to reactive hyperemia compared to amlodipine in patients with varying severities of essential hypertension?
ACE inhibitor therapy with imidapril improves endothelial function in mild to moderate, but not severe, essential hypertension, likely via increased nitric oxide production.
Imidapril may improve endothelial function versus amlodipine in mild-moderate hypertension; extends RCT evidence for severity-dependent ACEI vascular effects.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Higashi et al. (2002) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: